Insomnia: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• TNF 0
• GLP-1 0
• BDNF 0
• AKT 0
• APOE 0
• CDK4/6 0
• CGRP 0
• COX-2 0
• G6PD 0
• GIP 0
• HSP90 0
• HTT 0
• IL-4 0
• IL-6 0
• JAK 0
• MAPT 0
• mTOR 0
• PARP 0
• PCSK9 0
• PI3K 0
• TLR4 0
• TTR 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Brain monitoring in ICU via continuous pupillometry in closed eyes conditions (Ocumind)

  Tel Aviv University· Tel Aviv, Israel· EU contribution €150,000· until Jan 2028

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Sleep Enhancement with Portable Temporal Interference Neuromodulation (SLEEP-TI)

  Linkopings Universitet· Linkoping, Sweden· EU contribution €150,000· until May 2027· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Feeling awake while asleep: A neurophenomenological study of sleep state misperception in insomnia and narcolepsy (PhenoSSM)

  Institut du Cerveau Et de la Moelle Epiniere· Paris, France· EU contribution €242,261· until Sept 2027

• European Commission (Horizon Europe) · HORIZON-ERC

  Overnight Vulnerable Emotion Reset Normalizing Invalidating Generalized Hyperaroused Tension (OVERNIGHT)

  Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw· Amsterdam, Netherlands· EU contribution €2,500,000· until Dec 2027· 2 countries

• European Commission (Horizon 2020) · ERC-STG

  Tweaking dreams: non-invasive modulation of the level and content of mental activity during sleep (TweakDreams)

  Scuola Imt (Istituzioni, Mercati, Tecnologie) Alti Studi di Lucca· Lucca, Italy· EU contribution €1,488,270· until Apr 2027

  The disease is named only in the funder's project summary, not in the title.

5 of 5 running projects, newest first. Listed amounts together: €4.5m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Mendelian Randomization Analysis 41
• Gene Expression Profiling 9
• Exome Sequencing 1
• Proteomics 8
• Metabolomics 7
• Mass Spectrometry 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 66
• Machine Learning 34
• Deep Learning 3
• Cohort Studies 86
• Genome-Wide Association Study 37

• Inhibitory neurotransmission in frontostriatal circuitry: implications for psychomotor and vegetative symptoms in depressive episodes.

  BMC Psychiatry, Aug 2026

• Overnight sleep features and next-morning brain metabolism in older adults.

  Sleep Med, Jun 2026

• Efficient synthesis of [¹¹C]ramelteon as a positron emission tomography probe for imaging melatonin receptors involved in circadian rhythms.

  Chem Pharm Bull (Tokyo), Jan 2011

See which targets of this disease your abstract mentions, and go to the people working on them.